NO20071826L - 1,5-diheterosykel-1H-triazolderivat - Google Patents
1,5-diheterosykel-1H-triazolderivatInfo
- Publication number
- NO20071826L NO20071826L NO20071826A NO20071826A NO20071826L NO 20071826 L NO20071826 L NO 20071826L NO 20071826 A NO20071826 A NO 20071826A NO 20071826 A NO20071826 A NO 20071826A NO 20071826 L NO20071826 L NO 20071826L
- Authority
- NO
- Norway
- Prior art keywords
- diheterosykel
- triazole
- salt
- cox
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det beskrives en forbindelse representert ved Formel (I): hvor Ar1, Ar2, R1 og R2 hver representerer en substituent, et salt derav, eller et solvat av forbindelsen eller saltet og til en medisin inneholdende samme. Ifølge foreliggende oppfinnelse er det tilveiebrakt et kraftig blodplateaggregeringsundertrykkende middel som ikke hemmer COX-1 og COX-2.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004303851 | 2004-10-19 | ||
PCT/JP2005/019207 WO2006043594A1 (ja) | 2004-10-19 | 2005-10-19 | 1,5-ジ複素環-1h-トリアゾール誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20071826L true NO20071826L (no) | 2007-06-14 |
Family
ID=36203009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20071826A NO20071826L (no) | 2004-10-19 | 2007-04-10 | 1,5-diheterosykel-1H-triazolderivat |
Country Status (13)
Country | Link |
---|---|
US (1) | US20080125409A1 (no) |
EP (1) | EP1803719A4 (no) |
JP (1) | JPWO2006043594A1 (no) |
KR (1) | KR20070063530A (no) |
CN (1) | CN101039934A (no) |
AU (1) | AU2005296582A1 (no) |
CA (1) | CA2583153A1 (no) |
IL (1) | IL182538A0 (no) |
MX (1) | MX2007004643A (no) |
NO (1) | NO20071826L (no) |
RU (1) | RU2007118659A (no) |
WO (1) | WO2006043594A1 (no) |
ZA (1) | ZA200703562B (no) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05011276A (es) * | 2003-04-21 | 2006-01-24 | Daiichi Seiyaku Co | Derivado heterociclico de cinco miembros. |
JP6767878B2 (ja) | 2014-06-06 | 2020-10-14 | リサーチ トライアングル インスティテュート | アペリン受容体(apj)アゴニストおよびそれらの使用 |
PE20190258A1 (es) | 2015-12-09 | 2019-02-25 | Res Triangle Inst | Antagonistas del receptor de la apelina (apj) mejorados y usos de los mismos |
KR102541080B1 (ko) * | 2016-10-12 | 2023-06-08 | 리서치 트라이앵글 인스티튜트 | 복소환식 아펠린 수용체(apj) 작용제 및 이의 용도 |
JP2023548353A (ja) * | 2020-11-05 | 2023-11-16 | バイエル・アクチエンゲゼルシヤフト | 有用植物および作物植物の保護のための毒性緩和剤としての[(1,5-ジヘテロアリール-1h-1,2,4-トリアゾール-3-イル)オキシ]酢酸誘導体 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR878201A0 (en) * | 2001-11-09 | 2001-12-06 | Fujisawa Pharmaceutical Co., Ltd. | New compounds |
WO2004060367A1 (en) * | 2002-12-30 | 2004-07-22 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole and triazole derivatives useful as selective cox-1 inhibitors |
DE602004028800D1 (en) * | 2003-02-07 | 2010-10-07 | Daiichi Sankyo Co Ltd | Pyrazolderivat |
MXPA05011276A (es) * | 2003-04-21 | 2006-01-24 | Daiichi Seiyaku Co | Derivado heterociclico de cinco miembros. |
-
2005
- 2005-10-19 KR KR1020077008162A patent/KR20070063530A/ko not_active Application Discontinuation
- 2005-10-19 MX MX2007004643A patent/MX2007004643A/es unknown
- 2005-10-19 US US11/577,476 patent/US20080125409A1/en not_active Abandoned
- 2005-10-19 RU RU2007118659/04A patent/RU2007118659A/ru not_active Application Discontinuation
- 2005-10-19 ZA ZA200703562A patent/ZA200703562B/xx unknown
- 2005-10-19 CA CA002583153A patent/CA2583153A1/en not_active Abandoned
- 2005-10-19 WO PCT/JP2005/019207 patent/WO2006043594A1/ja active Application Filing
- 2005-10-19 JP JP2006543037A patent/JPWO2006043594A1/ja active Pending
- 2005-10-19 EP EP05795875A patent/EP1803719A4/en not_active Withdrawn
- 2005-10-19 AU AU2005296582A patent/AU2005296582A1/en not_active Abandoned
- 2005-10-19 CN CNA2005800352283A patent/CN101039934A/zh active Pending
-
2007
- 2007-04-10 NO NO20071826A patent/NO20071826L/no not_active Application Discontinuation
- 2007-04-12 IL IL182538A patent/IL182538A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20080125409A1 (en) | 2008-05-29 |
CA2583153A1 (en) | 2006-04-27 |
IL182538A0 (en) | 2007-09-20 |
WO2006043594A1 (ja) | 2006-04-27 |
EP1803719A4 (en) | 2008-07-02 |
EP1803719A1 (en) | 2007-07-04 |
CN101039934A (zh) | 2007-09-19 |
RU2007118659A (ru) | 2008-11-27 |
AU2005296582A1 (en) | 2006-04-27 |
KR20070063530A (ko) | 2007-06-19 |
JPWO2006043594A1 (ja) | 2008-05-22 |
MX2007004643A (es) | 2007-06-08 |
ZA200703562B (en) | 2008-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090295L (no) | Substituerte heteroarylderivater | |
TW200505447A (en) | Pyrazole derivative | |
MA29549B1 (fr) | Arylpyrazoles substitues destines a etre utilises contre des parasites | |
NO20063449L (no) | Substituerte heterocykler og deres anvendelse | |
NO20023688L (no) | Integrinekspresjonsinhibitorer | |
NO20061793L (no) | 1,4-disubstituerte isoquinilonderlvater som RAF-kinaseinhibitorer nyttige for behandling av proliferative sykdommer | |
EA200401613A1 (ru) | Лекарственное средство для лечения рака | |
BRPI0508632A (pt) | derivados de n1 ((pirazol-1-ilmetil)-2-metilfenil)-ftalamida e compostos inseticidas relacionados | |
NO20054854L (no) | Femrings heterocykliske derivater | |
NO20074583L (no) | Substiverte bis aryl- og heteroarylforbindelser som selektive 5HT2A antaconister | |
NO20085176L (no) | Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter | |
NO20054083L (no) | Nye sammenkoblede triazoloner og deres anvendelse | |
NO20074718L (no) | BCRP/ABCG2 inhibitor | |
NO20071826L (no) | 1,5-diheterosykel-1H-triazolderivat | |
NO20081125L (no) | Antitumor middel | |
DK1483245T3 (da) | 5-substituerede alkylaminopyrazolderivater som pesticider | |
NO20070564L (no) | Kinoliner uten tiazolinonsubstituenter. | |
NO20060718L (no) | Substituerte tiofoner og deres anvendelse | |
NO20061045L (no) | Imidazolderivater | |
CR9391A (es) | Derivados de indanil-piperazinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
NO20075080L (no) | Pyridylmetylsulfonderivater | |
NO20043211L (no) | Imidazo [1,2-a]pyridinderivat | |
NO20073710L (no) | Kjemiske forbindelser | |
NO20090741L (no) | Imino-imidazo-pyridinderivater med antitrombotisk aktivitet | |
UY28512A1 (es) | Difluoralquenos nematicidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |